Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 6
1992 4
1993 3
1994 5
1995 4
1996 8
1997 7
1998 8
1999 12
2000 7
2001 10
2002 11
2003 10
2004 7
2005 8
2006 8
2007 7
2008 7
2009 9
2010 14
2011 12
2012 12
2013 4
2014 11
2015 12
2016 11
2017 9
2018 12
2019 12
2020 18
2021 23
2022 14
2023 17
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

300 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, Colombo A, Fyles A, Baron MH, Jürgenliemk-Schulz IM, Kitchener HC, Nijman HW, Wilson G, Brooks S, Carinelli S, Provencher D, Hanzen C, Lutgens LCHW, Smit VTHBM, Singh N, Do V, D'Amico R, Nout RA, Feeney A, Verhoeven-Adema KW, Putter H, Creutzberg CL; PORTEC study group. de Boer SM, et al. Lancet Oncol. 2018 Mar;19(3):295-309. doi: 10.1016/S1470-2045(18)30079-2. Epub 2018 Feb 12. Lancet Oncol. 2018. PMID: 29449189 Free PMC article. Clinical Trial.
Reply.
Newman H, Perlman I, Pras E, Rozenberg A, Ben-Yosef T, Iovino C, Simonelli F, Di Iorio V, Rotenstreich Y, Katzburg E, Ehrenberg M, Iglicki M, Zur D. Newman H, et al. Among authors: pras e. Retina. 2022 Oct 1;42(10):e49. doi: 10.1097/IAE.0000000000003564. Retina. 2022. PMID: 36129272 No abstract available.
Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma.
Creutzberg CL, Nout RA, Lybeert ML, Wárlám-Rodenhuis CC, Jobsen JJ, Mens JW, Lutgens LC, Pras E, van de Poll-Franse LV, van Putten WL; PORTEC Study Group. Creutzberg CL, et al. Among authors: pras e. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e631-8. doi: 10.1016/j.ijrobp.2011.04.013. Epub 2011 Jun 2. Int J Radiat Oncol Biol Phys. 2011. PMID: 21640520 Free article. Clinical Trial.
A nationwide genetic analysis of inherited retinal diseases in Israel as assessed by the Israeli inherited retinal disease consortium (IIRDC).
Sharon D, Ben-Yosef T, Goldenberg-Cohen N, Pras E, Gradstein L, Soudry S, Mezer E, Zur D, Abbasi AH, Zeitz C, Cremers FPM, Khan MI, Levy J, Rotenstreich Y, Birk OS, Ehrenberg M, Leibu R, Newman H, Shomron N, Banin E, Perlman I. Sharon D, et al. Among authors: pras e. Hum Mutat. 2020 Jan;41(1):140-149. doi: 10.1002/humu.23903. Epub 2019 Sep 15. Hum Mutat. 2020. PMID: 31456290
Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials.
Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. J Clin Oncol. 2008 Dec 10;26(35):5802-12. doi: 10.1200/JCO.2008.16.4368. Epub 2008 Nov 10. J Clin Oncol. 2008. PMID: 19001332 Free PMC article. Review.
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.
de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, D'Amico R, Fyles A, Baron MH, Jürgenliemk-Schulz IM, Kitchener HC, Nijman HW, Wilson G, Brooks S, Gribaudo S, Provencher D, Hanzen C, Kruitwagen RF, Smit VTHBM, Singh N, Do V, Lissoni A, Nout RA, Feeney A, Verhoeven-Adema KW, Putter H, Creutzberg CL; PORTEC Study Group. de Boer SM, et al. Lancet Oncol. 2019 Sep;20(9):1273-1285. doi: 10.1016/S1470-2045(19)30395-X. Epub 2019 Jul 22. Lancet Oncol. 2019. PMID: 31345626 Free PMC article. Clinical Trial.
Psychiatric Comorbidities Associated With Keratoconus.
Safir M, Hecht I, Heller D, Pras E, Lifshitz M, Einan-Lifshitz A. Safir M, et al. Among authors: pras e. JAMA Ophthalmol. 2023 Dec 1;141(12):1145-1150. doi: 10.1001/jamaophthalmol.2023.5176. JAMA Ophthalmol. 2023. PMID: 37943540
Between-eye correlation of ocular parameters.
Hecht I, Shemer A, Vardi M, Braudo S, Dubinsky-Pertzov B, Or L, Pras E. Hecht I, et al. Among authors: pras e. Can J Ophthalmol. 2024 Jan 11:S0008-4182(23)00389-7. doi: 10.1016/j.jcjo.2023.12.009. Online ahead of print. Can J Ophthalmol. 2024. PMID: 38219792
Diagnostic capabilities of ChatGPT in ophthalmology.
Shemer A, Cohen M, Altarescu A, Atar-Vardi M, Hecht I, Dubinsky-Pertzov B, Shoshany N, Zmujack S, Or L, Einan-Lifshitz A, Pras E. Shemer A, et al. Among authors: pras e. Graefes Arch Clin Exp Ophthalmol. 2024 Jan 6. doi: 10.1007/s00417-023-06363-z. Online ahead of print. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 38183467
300 results